期刊文献+

基于透明质酸的靶向纳米给药系统的研究进展 被引量:11

Progress in Hyaluronic Acid-based Targeted Nano-drug Delivery Systems
原文传递
导出
摘要 透明质酸具有无毒、免疫原性低、可生物降解等优点,同时在体内有多种受体,如CD44受体,可通过受体-配体机制实现靶向药物递送的目的。本文综述了各种基于透明质酸的纳米给药系统(包括药物偶联物、纳米凝胶、纳米胶束和纳米粒)的形成、物理化学特点、生物学性质及其应用,展望了其发展趋势和应用前景。 Hyaluronic acid (HA) possesses lots of advantages such as non-toxicity, low immunogenicity and biodegradability. The active targeting effect can be achieved through the interaction between HA and its receptors, especially CD 44. The purpose of this paper is to review the formulations, physicochemical and biological properties of HA-based targeted nano-drug delivery systems, such as HA-drug conjugates, nanogels, nanomicelles and nanoparticles. Trends and prospects of developments and applications of HA are introduced.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2013年第8期828-835,共8页 Chinese Journal of Pharmaceuticals
关键词 透明质酸 CD44 纳米给药系统 靶向 综述 hyaluronic acid CD 44 nano-drug delivery system targeting review
  • 相关文献

参考文献44

  • 1Ghosh SC, Neslihan Alpay S, Klostergaard J. CD44: a validated target for improved delivery of cancer therapeutics [J]. Expert Opin Ther Targets, 2012, 16 (7): 635-650.
  • 2Singh Y, Palombo M, Sinko PJ. Recent trends in targeted anticancer prodrug and conjugate design [J]. Curr Med Chem, 2008, 15 (18): 1802-1826.
  • 3Luo Y, Prestwich GD. Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate [J]. Bioconjug Chem, 1999, 10(5):755-763.
  • 4Luo Y, Ziebell MR, Prestwich GD. A hyaluronic acid- taxol antitumor bioconjugate targeted to cancer cells [J]. Biomacromolecules, 2000, 1 (2) : 208-218.
  • 5Galer CE, Sano D, Ghosh SC, et al. Hyaluronic acid- paclitaxel conjugate inhibits growth of human squamous cell carcinomas of the head and neck via a hyaluronic acid- mediated mechanism [J]. Oral Oncol, 2011, 47(11) : 1039-1047.
  • 6Lee H, Lee K, Park TG. Hyaluronic acid-paclitaxel conjugate micelles: synthesis, characterization, and antitumor activity [J]. Bioconjug Chem, 2008, 19(6): 1319-1325.
  • 7Rosato A, Banzato A, De Luca G, et al. HYTADI-p20: a new paclitaxel-hyaluronic acid hydrosoluble bioconjugate for treatment of superficial bladder cancer [J]. Urol Oncol, 2006, 24(3): 207-215.
  • 8Xin D, Wang Y, Xiang J. The use of amino acid linkers in the conjugation of paclitaxel with hyaluronic acid as drug delivery system: synthesis, self-assembled property, drugrelease, and in vitro efficiency [J]. Pharm Res, 2010, 27 (2): 380-389.
  • 9Luo Y, Bernshaw N J, Lu ZR, et al. Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates [J]. Pharm Res, 2002, 19 (4) : 396-402.
  • 10Cai S, Thati S, Bagby TR, et al. Localized doxorubicin chemotherapy with a biopolymeric nanocarrier improves survival and reduces toxicity in xenografts of human breast cancer [J]. J Controlled Release, 2010, 146 (2) : 212-218.

同被引文献146

  • 1蔡成龙,杜庆伟,陈文静,于蓓蓓,孙丹丹,闫雪生.基于透明质酸的药物载体在中药制剂中的应用进展[J].当代化工,2020(9):1958-1964. 被引量:3
  • 2王兵,王亚新,赵红燕,宗岩,徐俊杰.甘草的主要成分及其药理作用的研究进展[J].吉林医药学院学报,2013,34(3):215-218. 被引量:123
  • 3许霞辉,贺兼斌,张平.人参皂苷Rg3联合苏拉明对小鼠肺癌生长影响及其机制的探讨[J].中华肿瘤防治杂志,2013,20(2):97-101. 被引量:12
  • 4Jianqin Lu. PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers[J]. Biomate- rials,2013,34(5) :1591-1600.
  • 5Zhang Q,Tang J, Fu L, et al. A p H-responsive a-helical cell pen- etrating peptide-mediated liposomal delivery system[J]. Biomate- rials, 2013,34(32) : 7980-7993.
  • 6Shah N,Chaudhari K,Dantuluri P,et al. Paclitaxel-loaded PLGA nanparticles surface modified with transferrin and Pluronic_ P85, an in vitro cell line and in vivo biodistribution studies on rat mod-el[J].J Drug Target,2009,17(7):533-542.
  • 7Gan CW,Feng SS. Transferrin-conjugated nanoparticles of Poly (lactide)-D-a-Tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain bar- rier[J]. Biomaterials,2010,31(30) :7748-7757.
  • 8Ulhrich K, Hekmatara T, Herbert E, et al. Transferrin- and transfer- rin receptor- antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB)[J]. Eur J Pharm Biopharm, 2009,71 (2) :251-256.
  • 9Jiang X,Xin H, Gu J, et al. Solid tumor penetration by integrin- mediated pegylatedpoly (trimethylene-carbonate) nanoparticles loaded with paclitaxel[J]. Biomaterials 2013,34(6):1739-1746.
  • 10Qin Y, Chen H,Zhang Q, et al. Liposome formulated with TAT- modified cholesterol for improving brain delivery and therapeu- ticefficacy on brain glioma in animals[J]. Int J Pharm, 2011,420 (2) :304-312.

引证文献11

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部